ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2022 American Transplant Congress

    Immunomodulation in Lung Transplant May Facilitate Transformation of Usual Interstitial Pneumonia Into Pleuroparenchymal Fibroelastosis

    Q. Cai1, K. Batra2, J. R. Torrealba1

    1Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, 2Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, TX

    *Purpose: Pleuroparenchymal fibroelastosis (PPFE) is a rare but distinctive manifestation of interstitial lung disease (ILD) characterized by a highly elastotic pattern of lung fibrosis. Its…
  • 2022 American Transplant Congress

    B and Plasma Cell Populations Drive Chronic Rejection After Lung Transplantation

    M. Bueno1, N. F. Smirnova2, K. Riemondy3, P. Suresh1, M. Brown1, X. Wang1, S. Collins4, J. Sembrat1, M. Koenigshoff1, M. Snyder1, J. McDyer1, O. Eickelberg1

    1Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, 2I2MC, INSERM UMR1297, Toulouse, France, 3Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 4Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO

    *Purpose: Chronic lung allograft dysfunction (CLAD) remains the major determinant of morbidity and mortality post-lung transplantation (LTx). Bronchiolitis obliterans syndrome (BOS) is the most prevalent…
  • 2022 American Transplant Congress

    Impact Of Antifungal Prophylaxis Discontinuation On Immunosuppression In Lung Transplant Recipients

    R. Huntsman, K. Neuhaus

    Pharmacy, Cleveland Clinic, Cleveland, OH

    *Purpose: The purpose of this study is to characterize the impact of antifungal discontinuation on immunosuppressant levels and incidence of acute rejection and fungal infections…
  • 2022 American Transplant Congress

    Differing Gene Expression Profiles and Signaling Pathways Observed Between Alloreactive and Tolerant T Cells in a Recipient Following Bilateral Orthotopic Lung Transplant (BOLT) and Bone Marrow Transplant (BMT) from the Same Cadaveric UNOS Donor

    P. Szabolcs, E. Garchar, D. Rajasundaram, X. Chen

    UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA

    *Purpose: Primary immunodeficiency (PID) patients may develop pulmonary complications, and most are ineligible for either BOLT or BMT due to futility. A prospective trial in…
  • 2022 American Transplant Congress

    Emphysematous Cystitis in a Lung Transplant Recipient with BK Viremia

    D. Razia, J. Klein, H. Mohamed, A. Arjuna

    Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ

    *Purpose: Emphysematous cystitis (EC) is a rare urinary tract infection from E. coli or K. pneumoniae in diabetics or immunocompromised individuals, resulting in sepsis and…
  • 2022 American Transplant Congress

    Mitochondrial Dysfunction and Alloimmunity in Chronic Lung Transplant Rejection

    M. Cano1, D. Zhou2, C. Chen3, K. Pugh4, D. Byers1, D. Kreisel5, R. Hachem1, A. Gelman5

    1Pulmonary and Critical Care, Washington University, Saint Louis, MO, 2Surgery, Washington University, Saint Louis, MO, 3Pulmonary and Critical Care, UT Southwestern Medical Center, Dallas, TX, 4Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, 5Surgery and Immunology and Pathology, Washington University, Saint Louis, MO

    *Purpose: Bronchiolitis obliterans syndrome (BOS) remains a major cause of death after lung transplantation. Unfortunately, we lack effective treatments for BOS as the mechanisms by…
  • 2022 American Transplant Congress

    Nebulized Mitochondria Localize to Transplanted Allografts and Improve Outcomes Following Lung Transplantation

    D. Nord1, Z. Tu2, L. Langerude1, A. McQuiston1, J. Kwon3, S. Nadig4, T. Machuca5, C. Atkinson1

    1Pulmonary Medicine, University of Florida, Gainesville, FL, 2University of Florida, Gaineville, FL, 3MUSC College of Medicine, Charleston, SC, 4Northwestern University, Charleston, SC, 5Department of Surgery, University of Florida, Gainesville, FL

    *Purpose: Mitochondrial transplantation therapy is an innovative strategy for the treatment of mitochondrial dysfunction. The approach has shown efficacy in the treatment of cardiac ischemic…
  • 2022 American Transplant Congress

    Telemedicine Implementation in Solid Organ Transplant (SOT) Clinics is Associated with Satisfaction Among Patients and Providers but Increased Burden on Staff

    C. W. Wang, N. Ha, M. Duarte, C. B. Sherman

    University of California, San Francisco, San Francisco, CA

    *Purpose: Telemedicine is an essential part of healthcare delivery and has grown exponentially during the COVID-19 pandemic. Data on optimal utilization and implementation of telemedicine…
  • 2022 American Transplant Congress

    Alemtuzumab and Basilximab Induction Therapy in Lung Transplantation

    M. Furukawa, E. Chan, P. G. Sanchez

    Cardiothoracic Surgery, UPMC, Pittsburgh, PA

    *Purpose: Induction therapy is used in about more than 80% of lung transplant centers and is increasing globally. Currently, there are no standards or guideline…
  • 2022 American Transplant Congress

    Spectrum of Pre-Transplant Esophagram Abnormalities and Association with Long-Term Outcomes

    I. Lill1, D. Lovin2, A. C. Lawrence2, M. Mohanka2, J. Joerns2, S. Bollineni2, I. L. Timofte2, V. Kaza2, M. Wait3, F. Torres2, A. Banga2

    1University of Texas - Southwestern, Dallas, TX, 2Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas - Southwestern, Dallas, TX, 3Cardiovascular & Thoracic Surgery, University of Texas - Southwestern, Dallas, TX

    *Purpose: To determine the frequency and type of esophageal abnormalities on screening esophagram during the pre-transplant evaluation and evaluate the association of these abnormalities on…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences